Loading…

Substance Use-related Co-morbidities and Health-related Outcomes

Select Protocol ID

Global Appraisal of Individual Needs - Short Screener (GAIN-SS)
#560102

National HIV Behavioral Surveillance System, 2010
#560201

National Epidemiologic Survey on Alcohol and Related Conditions-III (NESARC-III)
#560303

National Epidemiologic Survey on Alcohol and Related Conditions-III (NESARC-III)
#560304

EQ-5D-3L
#560403

EuroQol Group - EQ-5D-Y
#560402

Global Appraisal of Individual Needs (GAIN), Self-Help Involvement Scale (SHIS)
#560602

Global Appraisal of Individual Needs (GAIN)
#560702

Global Appraisal of Individual Needs (GAIN), General Victimization Scale (GVS)
#560802
Release Date:

February 24, 2012; reviewed November 21, 2016

Scope of Collection
Element Considered Final Measures in Toolkit
Additional clinical considerations (intervention, prevention including type of treatment, success & relapse) specific to certain drugs Duration of Abstinence - Alcohol
Duration of Abstinence - Substance Use
Medical and psychiatric comorbidities Behavioral Health Screener
Victimization Screener
HIV/AIDS & risk behaviors Comprehensive HIV Risk Assessment
Treatment history Substance Abuse Treatment, Participation, and Involvement
Self-Help Involvement
Service Utilization and Cost
Working Group Roster:

WG Members:

Frank Chaloupka, PhD, Co-Chair
University of Illinois at Chicago
Department of Economics
Chicago, IL
Patrick Flynn, PhD, Co-Chair
Texas Christian University
Forth Worth, TX
Redonna Chandler, PhD
National Institute on Drug Abuse (NIDA)
Rockville, MD
Michael Dennis, PhD
Chestnut Health Systems
Bloomington, IL
Dionne Godette, PhD
National Institute on Alcohol Abuse and Alcoholism (NIAAA)
Bethesda, MD
Ed Nunes, PhD
Columbia University Medical Center
New York, NY
Rosalie Pacula, PhD
RAND Corporation
Santa Monica, CA
Kay L. Wanke, PhD, MPH
Office of Disease Prevention (ODP)
Tobacco Regulatory Science Program
Rockville, MD

Substance Abuse and Addiction Panel Liaison, WG Manager and WG Supervisor:

Andrea Hussong, PhD, SAA Scientific Panel Liaison
University of North Carolina at Chapel Hill
Chapel Hill, NC
Paul Wakim, PhD, SAA Scientific Panel Liaison
National Institute on Drug Abuse (NIDA)
Rockville, MD
Tabitha P. Hendershot, BA, WG Supervisor
RTI International
Washington, DC
Destiney Nettles, MPM, WG Manager
RTI International
Research Triangle Park, NC

Supplemental Information includes protocols that the Working Group or Expert Review Panel considered useful and highly relevant to the domain but do not meet the criteria for inclusion in the Toolkit.

Substance Use-related Co-morbidities and Health-related Supplemental Information includes:
Additional Information:

There is no additional information for this collection.